NYSE: MOS
Mosaic
Materials · Agricultural Chemicals
52-week range
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$6.74B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.3B |
| FY2017, ended Dec 31, 2017 | $9.88B |
| FY2018, ended Dec 31, 2018 | $11.3B |
| FY2019, ended Dec 31, 2019 | $8.20B |
| FY2020, ended Dec 31, 2020 | $8.72B |
| FY2021, ended Dec 31, 2021 | $14.5B |
| FY2022, ended Dec 31, 2022 | $14.8B |
| FY2023, ended Dec 31, 2023 | $11.5B |
| FY2024, ended Dec 31, 2024 | $7.79B |
| FY2025, ended Dec 31, 2025 | $7.65B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.74B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$12.2B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.16B |
| FY2017, ended Dec 31, 2017 | $7.41B |
| FY2018, ended Dec 31, 2018 | $9.59B |
| FY2019, ended Dec 31, 2019 | $8.91B |
| FY2020, ended Dec 31, 2020 | $8.68B |
| FY2021, ended Dec 31, 2021 | $12.4B |
| FY2022, ended Dec 31, 2022 | $19.1B |
| FY2023, ended Dec 31, 2023 | $13.7B |
| FY2024, ended Dec 31, 2024 | $11.1B |
| FY2025, ended Dec 31, 2025 | $12.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $12.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $298M | $417M |
| FY2017, ended Dec 31, 2017 | −$107M | $115M |
| FY2018, ended Dec 31, 2018 | $470M | $455M |
| FY2019, ended Dec 31, 2019 | −$1.07B | −$177M |
| FY2020, ended Dec 31, 2020 | $666M | $412M |
| FY2021, ended Dec 31, 2021 | $1.63B | $898M |
| FY2022, ended Dec 31, 2022 | $3.58B | $2.69B |
| FY2023, ended Dec 31, 2023 | $1.16B | $1.00B |
| FY2024, ended Dec 31, 2024 | $175M | $47.4M |
| FY2025, ended Dec 31, 2025 | $541M | −$535M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | −$639M | −$947M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$294M
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $673M |
| FY2017, ended Dec 31, 2017 | $2.15B |
| FY2018, ended Dec 31, 2018 | $848M |
| FY2019, ended Dec 31, 2019 | $519M |
| FY2020, ended Dec 31, 2020 | $574M |
| FY2021, ended Dec 31, 2021 | $770M |
| FY2022, ended Dec 31, 2022 | $735M |
| FY2023, ended Dec 31, 2023 | $349M |
| FY2024, ended Dec 31, 2024 | $273M |
| FY2025, ended Dec 31, 2025 | $277M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $294M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.$5.86B
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.82B |
| FY2017, ended Dec 31, 2017 | $5.23B |
| FY2018, ended Dec 31, 2018 | $4.53B |
| FY2019, ended Dec 31, 2019 | $4.61B |
| FY2020, ended Dec 31, 2020 | $4.58B |
| FY2021, ended Dec 31, 2021 | $4.28B |
| FY2022, ended Dec 31, 2022 | $3.62B |
| FY2023, ended Dec 31, 2023 | $3.76B |
| FY2024, ended Dec 31, 2024 | $4.22B |
| FY2025, ended Dec 31, 2025 | $5.05B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $5.86B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 9.2% since 2016.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.318M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 350M |
| FY2017, ended Dec 31, 2017 | 385M |
| FY2018, ended Dec 31, 2018 | 385M |
| FY2019, ended Dec 31, 2019 | 379M |
| FY2020, ended Dec 31, 2020 | 379M |
| FY2021, ended Dec 31, 2021 | 368M |
| FY2022, ended Dec 31, 2022 | 336M |
| FY2023, ended Dec 31, 2023 | 322M |
| FY2024, ended Dec 31, 2024 | 317M |
| FY2025, ended Dec 31, 2025 | 318M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 318M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Jun 30, 2026. Hover or tap a column for another year.Net: $31.1M more issued than bought back
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $75.0M | $30.5M | — |
| FY2017, ended Dec 31, 2017 | $0 | $28.0M | — |
| FY2018, ended Dec 31, 2018 | $0 | $27.5M | $920M |
| FY2019, ended Dec 31, 2019 | $150M | $27.9M | — |
| FY2020, ended Dec 31, 2020 | $0 | $17.8M | — |
| FY2021, ended Dec 31, 2021 | $411M | $29.5M | — |
| FY2022, ended Dec 31, 2022 | $1.67B | $27.9M | — |
| FY2023, ended Dec 31, 2023 | $756M | $33.0M | — |
| FY2024, ended Dec 31, 2024 | $235M | $31.8M | — |
| FY2025, ended Dec 31, 2025 | $0 | $30.7M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $31.1M | — |
Revenue (TTM)
$12.2B
+8.8% YoY
Net income (TTM)
−$639M
−168% YoY
Cash
$294M
+2.7% YoY
Total debt
$5.86B
+32.7% YoY
Valuation
At current price- Market Cap
- $5.85B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.5×
- Price / Book
- 0.5×
- EV / EBITDA
- 11.6×
Growth
Trailing 12 months- Revenue (TTM)
- $12.2B
- Revenue Growth YoY
- 8.8%
- Revenue CAGR 3Y
- −14.3%
- Revenue CAGR 5Y
- 6.8%
- EPS Growth YoY
- −168%
- Net Income Growth YoY
- −168%
Profitability
Trailing 12 months- Gross Margin
- 11.0%
- Operating Margin
- −1.4%
- Net Margin
- −5.2%
- FCF Margin
- −7.7%
- Return on Equity
- −5.3%
Earnings
Trailing 12 months- Net Income
- −$639M
- EPS (diluted)
- −$2.01
- EBITDA
- $984M
- Operating Income
- −$170M
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $294M
- Total Debt
- $5.86B
- Net Debt
- $5.56B
- Total Assets
- $24.6B
- Total Liabilities
- $13.0B
- Shareholders' Equity
- $11.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $444M
- Capital Expenditure
- $1.39B
- Free Cash Flow
- −$947M
Dividends and risk
Last 12 months- Dividend Yield
- 4.8%
- Dividend / Share
- $0.88
- Beta (5Y)
- 0.91
Every ratio is calculated from the company’s reported figures.
Strength
Revenue is up 8.8% year over year, at $12.2B.
Watch
Lost $639M over the last 12 months.
Watch
Net debt is 5.7× EBITDA ($5.56B), a heavy load.
Watch
Free cash flow was negative (−$947M) over the last year.
Written by fixed rules from the reported figures, not by a person or an AI.
Latest report
Pro10-K for the fiscal year ended Dec 31, 2025 · filed Feb 27, 2026
The score and findings for the newest report are part of CoreStock Pro, coming soon. Every earlier report is free.
Score of each annual report
0 to 100 · 60 means nothing notable · tap a column for its details
2024 · 10-K40Serious concerns
10-K for the fiscal year ended Dec 31, 2024
Filed Mar 3, 2025 · Read the filing on EDGAR
- Sales fell 19% to $11.1 billion and net earnings fell 85% to $175 million, on lower potash and Brazil prices and lower volumes.
- A $686 million currency loss hit earnings, partly offset by a $522 million gain from swapping the Saudi joint venture stake for Ma'aden shares.
- Phosphate volumes fell after a Riverview fire, hurricanes and maintenance, while Brazil's gross margin nearly doubled by favoring margin over volume.
- New 25% U.S. tariffs on Canadian imports, including potash, were paused for 30 days; Mosaic expects no significant impact but flags the risk.
Business momentum
Sharp deterioration
“Net earnings attributable to Mosaic for the year ended December 31, 2024 were $174.9 million, or $0.55 per diluted share, compared to $1.2 billion, or $3.50 per diluted share for 2023”
Outlook
Neutral
“At this time, we do not expect these tariffs to have a significant impact on our Potash business and operating results.”
Financial stress
Low
“At December 31, 2024, we had $2.5 billion available under our $2.5 billion revolving credit facility.”
Tone against the previous report
More negative
Red flags
- Minor
Major lawsuit
“The change from the prior year was primarily due to an arbitration reserve of approximately $52 million in the current year.”
Positives
Brazil gross margin nearly doubled despite lower sales
“Gross margin for the Mosaic Fertilizantes segment increased to $406.6 million for the year ended December 31, 2024, from $211.6 million in the prior year.”
Saudi joint venture stake exchanged for about $1.5 billion of Ma'aden shares at a gain
“The transaction closed on December 24, 2024 at a value of approximately $1.5 billion, resulting in a pre-tax gain of approximately $0.5 billion.”
Goodwill passed its annual test, easing the earlier worry about a Brazil write-down
“were in substantial excess of their respective carrying values and the goodwill for those units was not impaired”
Concerns
Potash profit nearly halved as selling prices dropped 25%
“Gross margin for the Potash segment decreased to $643.2 million in the current year, from $1.2 billion in the prior year period.”
Large currency swing, mostly non-cash, wiped out much of the year's earnings
“In 2024, we recorded a foreign currency transaction loss of $685.8 million, compared to a gain of $194.0 million in 2023.”
Operating cash flow fell sharply and barely covered capital spending
“For the year ended December 31, 2024, net cash provided by operating activities was $1.3 billion, compared to $2.4 billion in the prior year.”
New risks since the previous report
U.S. tariffs on Canadian potash and possible Canadian retaliation could raise costs and reduce farmer demand
“In February 2025, the U.S. imposed a 25% tariff on most imports from Canada, including potash crop nutrients.”
Federal court ruling on Florida wetlands permits could delay approvals for mining
“A recent federal court decision invalidated Florida’s Clean Water Act 404 “dredge and fill” permitting program and returned that permitting authority to the federal agencies.”
Brazilian customer credit problems led to a bad debt charge and a shift to lower-risk customers
“This was largely offset by approximately $30 million of bad debt reserve in our Mosaic Fertilizantes segment.”
Large minority stake in Ma'aden, which Mosaic does not control, now moves earnings and cash flow
“The operations and results of Ma'aden and some other companies are significant to us, and their operations can affect earnings.”
Biggest risks named
- Volatile fertilizer prices and intense competition from subsidized global producers
- U.S. tariffs on Canadian potash and changes to phosphate import duties
- Mine and plant disruptions from hurricanes, fires, brine inflows and tailings failures
- Rising environmental, permitting and site closure costs and financial assurance requirements
- Currency swings and customer credit risk, especially in Brazil
Artificial intelligence in this business: Not mentioned
How the score adds up
| Starting point | 60 | |
| Business momentum | −15 | |
| Outlook | 0 | |
| Tone against the previous report | −2 | |
| Financial stress | 0 | |
| Red flags | −1.2 | |
| New risks | −2 | |
| Score | 40 | |
Written by AI (Claude Opus 5.5) from the report’s text. 14 of 14 quotes were found word for word in the filing; the rest are left out. Not investment advice.
All scored reports
| Period | Report | Filed | Score | Momentum | Red flags |
|---|---|---|---|---|---|
| 10-K | Feb 27, 2026 | Pro | |||
| 10-K | Mar 3, 2025 | 40 | Sharp deterioration | 1 minor | |
| 10-K | Feb 22, 2024 | 41 | Sharp deterioration | 1 minor | |
| 10-K | Feb 23, 2023 | 68 | Strong improvement | 2 minor | |
| 10-K | Feb 23, 2022 | 74 | Strong improvement | 1 minor | |
| 10-K | Feb 22, 2021 | 66 | Improving | 1 medium1 minor | |
| 10-K | Feb 20, 2020 | 27 | Sharp deterioration | 4 medium1 minor | |
| 10-K | Mar 13, 2019 | 67 | Strong improvement | 1 medium1 minor | |
| 10-K | Feb 21, 2018 | 40 | Sharp deterioration | 3 medium1 minor | |
| 10-K | Feb 15, 2017 | 41 | Sharp deterioration | 1 medium1 minor |
How these scores work
An AI model reads the management discussion, risk factors and legal sections of each report and records what they say, quoting the filing word for word. Fixed rules then turn those findings into a score from 0 to 100, where 60 means nothing notable either way. A score describes the report, not whether the stock is a good investment, and the AI may know how things turned out later, which can colour older scores. Read the methodology
From the 10-Q for Q2 FY2026 (period ended Jun 30, 2026), filed Aug 5, 2026. View filings on SEC EDGAR